Sanara MedTech Inc. (SMTI) Misses Q2 EPS by 20c

Sanara MedTech Inc. (NASDAQ: SMTI) reported Q2 EPS of ($0.41), $0.20 worse than the analyst estimate of ($0.21). Revenue for the quarter came in at $20.2 million versus the consensus estimate of $19.2 million.

For earnings history and earnings-related data on Sanara MedTech Inc. (SMTI) click here.

You May Also Be Interested In

• loanDepot receives NYSE non-compliance notice over stock price
• Alzamend Neuro (ALZN) files for 98.4M share offering by selling stockholders
• Cytek faces $56M damages award in Beckman Coulter patent case